Literature DB >> 14625348

The small intestine as a xenobiotic-metabolizing organ.

Laurence S Kaminsky1, Qing-Yu Zhang.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 14625348     DOI: 10.1124/dmd.31.12.1520

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


× No keyword cloud information.
  55 in total

1.  Organ data from the developing Göttingen minipig: first steps towards a juvenile PBPK model.

Authors:  Els Van Peer; Noel Downes; Christophe Casteleyn; Chris Van Ginneken; Arie Weeren; Steven Van Cruchten
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-12-19       Impact factor: 2.745

Review 2.  The influence of cardiovascular physiology on dose/pharmacokinetic and pharmacokinetic/pharmacodynamic relationships.

Authors:  Pietro Fagiolino; Rosa Eiraldi; Marta Vázquez
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 3.  Early metabolism evaluation making traditional Chinese medicine effective and safe therapeutics.

Authors:  Yong Liu; Ling Yang
Journal:  J Zhejiang Univ Sci B       Date:  2006-02       Impact factor: 3.066

Review 4.  Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug.

Authors:  Hongjian Zhang; Donghui Cui; Bonnie Wang; Yong-Hae Han; Praveen Balimane; Zheng Yang; Michael Sinz; A David Rodrigues
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

5.  Pharmacokinetics and disposition of anlotinib, an oral tyrosine kinase inhibitor, in experimental animal species.

Authors:  Chen-Chun Zhong; Feng Chen; Jun-Ling Yang; Wei-Wei Jia; Li Li; Chen Cheng; Fei-Fei Du; Su-Ping Zhang; Cheng-Ying Xie; Na-Ting Zhang; Olajide E Olaleye; Feng-Qing Wang; Fang Xu; Li-Guang Lou; Dong-Ying Chen; Wei Niu; Chuan Li
Journal:  Acta Pharmacol Sin       Date:  2018-04-05       Impact factor: 6.150

6.  Role of intestinal cytochrome P450 (P450) in modulating the bioavailability of oral lovastatin: insights from studies on the intestinal epithelium-specific P450 reductase knockout mouse.

Authors:  Yi Zhu; Jaime D'Agostino; Qing-Yu Zhang
Journal:  Drug Metab Dispos       Date:  2011-02-24       Impact factor: 3.922

7.  Prediction of Drug Clearance from Enzyme and Transporter Kinetics.

Authors:  Priyanka R Kulkarni; Amir S Youssef; Aneesh A Argikar
Journal:  Methods Mol Biol       Date:  2021

Review 8.  Multiple NSAID-induced hits injure the small intestine: underlying mechanisms and novel strategies.

Authors:  Urs A Boelsterli; Matthew R Redinbo; Kyle S Saitta
Journal:  Toxicol Sci       Date:  2012-10-22       Impact factor: 4.849

9.  Characterization of the transmembrane transport and absolute bioavailability of the HCV protease inhibitor danoprevir.

Authors:  Barbara J Brennan; Agnès Poirier; Sebastian Moreira; Peter N Morcos; Petra Goelzer; Renée Portmann; Jiney Asthappan; Christoph Funk; Patrick F Smith
Journal:  Clin Pharmacokinet       Date:  2015-05       Impact factor: 6.447

10.  An intestinal epithelium-specific cytochrome P450 (P450) reductase-knockout mouse model: direct evidence for a role of intestinal p450s in first-pass clearance of oral nifedipine.

Authors:  Qing-Yu Zhang; Cheng Fang; Jin Zhang; Deborah Dunbar; Laurence Kaminsky; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2008-12-04       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.